Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gastric Cancer

  Free Subscription


02.12.2019

1 Am J Gastroenterol
1 Anticancer Res
1 Br J Surg
2 Endoscopy
1 Eur J Cancer
1 J Gastroenterol Hepatol
1 J Surg Oncol
1 Lancet Gastroenterol Hepatol
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. SHIN DW, Suh B, Lim H, Suh YS, et al
    Correction: Increased Risk of Osteoporotic Fracture in Postgastrectomy Gastric Cancer Survivors Compared With Matched Controls: A Nationwide Cohort Study in Korea.
    Am J Gastroenterol. 2019 Nov 22. doi: 10.14309/ajg.0000000000000473.
    PubMed     Text format    


    Anticancer Res

  2. KHING TM, Po WW, Sohn UD
    Fluoxetine Enhances Anti-tumor Activity of Paclitaxel in Gastric Adenocarcinoma Cells by Triggering Apoptosis and Necroptosis.
    Anticancer Res. 2019;39:6155-6163.
    PubMed     Text format     Abstract available


    Br J Surg

  3. DATTA J, Da Silva EM, Kandoth C, Song T, et al
    Poor survival after resection of early gastric cancer: extremes of survivorship analysis reveal distinct genomic profile.
    Br J Surg. 2019 Nov 25. doi: 10.1002/bjs.11443.
    PubMed     Text format     Abstract available


    Endoscopy


  4. Video Comment on Ming-Ming Zhang et al.
    Endoscopy. 2019;51:v15.
    PubMed     Text format    

  5. BYRNE MF
    Artificial intelligence and the future of endoscopy: should we be quietly excited?
    Endoscopy. 2019;51:511-512.
    PubMed     Text format    


    Eur J Cancer

  6. THOMAS A, Virdee PS, Eatock M, Lord SR, et al
    Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma.
    Eur J Cancer. 2019;124:131-141.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  7. SONG M, Rabkin CS, Torres J, Kemp TJ, et al
    Circulating inflammation-related markers and advanced gastric premalignant lesions.
    J Gastroenterol Hepatol. 2019;34:852-856.
    PubMed     Text format     Abstract available


    J Surg Oncol

  8. PEREIRA MA, Ramos MFKP, Dias AR, Cardili L, et al
    Lymph node regression after neoadjuvant chemotherapy: A predictor of survival in gastric cancer.
    J Surg Oncol. 2019 Nov 26. doi: 10.1002/jso.25785.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  9. KATAI H, Mizusawa J, Katayama H, Morita S, et al
    Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2019 Nov 19. pii: S2468-1253(19)30332.
    PubMed     Text format     Abstract available


    World J Surg

  10. OKAMURA A, Watanabe M, Kozuki R, Toihata T, et al
    Significance of Intramural Metastasis in Patients with Esophageal Squamous Cell Carcinoma: An Indicator of Aggressive Cancer Behavior.
    World J Surg. 2019;43:1997-2005.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: